The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
11/07/2022 | Angus Stewart | 10 min read
The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world
11/03/2022 | Rob Coker | 2 min read
AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria
11/02/2022 | Robyn Goforth | 3 min read
Insights into the quest to find an effective treatment for this socially painful condition
10/11/2022 | Fabiana Alves | 7 min read
How global collaborations are inching us toward a victory over a neglected parasitic disease
09/09/2022 | Angus Stewart | 7 min read
Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.
09/06/2022 | Sponsored by Veranova | 4 min read
As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.
09/05/2022 | Angus Stewart | 18 min read
How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates
09/02/2022 | Maryam Mahdi | 13 min read
What role must pharma play to help improve outcomes for women?
08/31/2022 | Angus Stewart | 7 min read
Based in Barcelona and Belgium, this startup company is bringing small molecules to the fight against X-linked leukodystrophy
08/18/2022 | Sponsored by Emulate Bio | 6 min read
How the Emulate Colon Intestine-Chip could help researchers develop breakthrough treatments for IBD.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse